Brimonidine Purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension.

@article{Netland2003BrimonidinePA,
  title={Brimonidine Purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension.},
  author={Peter A. Netland and M. I. Michael and Sarah A. Rosner and Barry Katzman and Jonathan I Macy},
  journal={Advances in therapy},
  year={2003},
  volume={20 1},
  pages={20-30}
}
This 3-month multicenter, investigator-masked, parallel-group study compared brimonidine Purite and bimatoprost (brimP/bim) with timolol gel-forming solution and latanoprost (tim/latan) in 28 patients with open-angle glaucoma or ocular hypertension. IOP was measured at baseline and 2 hours after morning instillation at weeks 2, 4, and 12. The primary outcome measure was the mean IOP reduction from baseline. Secondary measures were the percentage of patients in each group who achieved specific… CONTINUE READING